Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation

Hereditary transthyretin amyloid cardiomyopathy is cardiac involvement in systemic transthyretin amyloidosis. For the first time, we generated induced pluripotent stem cell (iPSC) line of hATTR-CM carrying the TTR mutation p.Asp38Asn. We isolated peripheral blood mononuclear cells from the patient’s...

Full description

Bibliographic Details
Main Authors: Shan He, Ye Jin, Zhuang Tian, TianRui Hua, HaiPing Xing, ShengSheng Zhuang, XinYue He, HanYu Li, Lun Wang, ShuYang Zhang
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506120303238
_version_ 1819203493203804160
author Shan He
Ye Jin
Zhuang Tian
TianRui Hua
HaiPing Xing
ShengSheng Zhuang
XinYue He
HanYu Li
Lun Wang
ShuYang Zhang
author_facet Shan He
Ye Jin
Zhuang Tian
TianRui Hua
HaiPing Xing
ShengSheng Zhuang
XinYue He
HanYu Li
Lun Wang
ShuYang Zhang
author_sort Shan He
collection DOAJ
description Hereditary transthyretin amyloid cardiomyopathy is cardiac involvement in systemic transthyretin amyloidosis. For the first time, we generated induced pluripotent stem cell (iPSC) line of hATTR-CM carrying the TTR mutation p.Asp38Asn. We isolated peripheral blood mononuclear cells from the patient’s peripheral blood. The reprogramming of PBMCs achieved a pluripotent state by the transfection of non-integrated episomal vectors. We demonstrated pluripotency with the presence of cell surface markers, the expression of pluripotency-related genes and the ability to form teratoma composed of three germ layers in vivo. This iPSC line is a useful model for studying the pathogenic mechanism of TTR p.Asp38Asn mutation.
first_indexed 2024-12-23T04:20:47Z
format Article
id doaj.art-b8f2b5ebe8c149a1b70a39159c6634d1
institution Directory Open Access Journal
issn 1873-5061
language English
last_indexed 2024-12-23T04:20:47Z
publishDate 2020-12-01
publisher Elsevier
record_format Article
series Stem Cell Research
spelling doaj.art-b8f2b5ebe8c149a1b70a39159c6634d12022-12-21T18:00:15ZengElsevierStem Cell Research1873-50612020-12-0149102022Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutationShan He0Ye Jin1Zhuang Tian2TianRui Hua3HaiPing Xing4ShengSheng Zhuang5XinYue He6HanYu Li7Lun Wang8ShuYang Zhang9Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100005, ChinaClinical Research Laboratory, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100005, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100005, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100005, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100005, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100005, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100005, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100005, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100005, ChinaDepartment of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100005, China; Correspondence author.Hereditary transthyretin amyloid cardiomyopathy is cardiac involvement in systemic transthyretin amyloidosis. For the first time, we generated induced pluripotent stem cell (iPSC) line of hATTR-CM carrying the TTR mutation p.Asp38Asn. We isolated peripheral blood mononuclear cells from the patient’s peripheral blood. The reprogramming of PBMCs achieved a pluripotent state by the transfection of non-integrated episomal vectors. We demonstrated pluripotency with the presence of cell surface markers, the expression of pluripotency-related genes and the ability to form teratoma composed of three germ layers in vivo. This iPSC line is a useful model for studying the pathogenic mechanism of TTR p.Asp38Asn mutation.http://www.sciencedirect.com/science/article/pii/S1873506120303238
spellingShingle Shan He
Ye Jin
Zhuang Tian
TianRui Hua
HaiPing Xing
ShengSheng Zhuang
XinYue He
HanYu Li
Lun Wang
ShuYang Zhang
Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation
Stem Cell Research
title Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation
title_full Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation
title_fullStr Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation
title_full_unstemmed Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation
title_short Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation
title_sort establishment of an induced pluripotent stem cell line pumchi004 a from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin ttr p asp38asn mutation
url http://www.sciencedirect.com/science/article/pii/S1873506120303238
work_keys_str_mv AT shanhe establishmentofaninducedpluripotentstemcelllinepumchi004afromahereditarytransthyretinamyloidcardiomyopathypatientwithtransthyretinttrpasp38asnmutation
AT yejin establishmentofaninducedpluripotentstemcelllinepumchi004afromahereditarytransthyretinamyloidcardiomyopathypatientwithtransthyretinttrpasp38asnmutation
AT zhuangtian establishmentofaninducedpluripotentstemcelllinepumchi004afromahereditarytransthyretinamyloidcardiomyopathypatientwithtransthyretinttrpasp38asnmutation
AT tianruihua establishmentofaninducedpluripotentstemcelllinepumchi004afromahereditarytransthyretinamyloidcardiomyopathypatientwithtransthyretinttrpasp38asnmutation
AT haipingxing establishmentofaninducedpluripotentstemcelllinepumchi004afromahereditarytransthyretinamyloidcardiomyopathypatientwithtransthyretinttrpasp38asnmutation
AT shengshengzhuang establishmentofaninducedpluripotentstemcelllinepumchi004afromahereditarytransthyretinamyloidcardiomyopathypatientwithtransthyretinttrpasp38asnmutation
AT xinyuehe establishmentofaninducedpluripotentstemcelllinepumchi004afromahereditarytransthyretinamyloidcardiomyopathypatientwithtransthyretinttrpasp38asnmutation
AT hanyuli establishmentofaninducedpluripotentstemcelllinepumchi004afromahereditarytransthyretinamyloidcardiomyopathypatientwithtransthyretinttrpasp38asnmutation
AT lunwang establishmentofaninducedpluripotentstemcelllinepumchi004afromahereditarytransthyretinamyloidcardiomyopathypatientwithtransthyretinttrpasp38asnmutation
AT shuyangzhang establishmentofaninducedpluripotentstemcelllinepumchi004afromahereditarytransthyretinamyloidcardiomyopathypatientwithtransthyretinttrpasp38asnmutation